Table of Content
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tourette Syndrome - Overview
Tourette Syndrome - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Tourette Syndrome - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tourette Syndrome - Companies Involved in Therapeutics Development
Adeptio Pharmaceuticals Ltd
Asari Pharma AB
Catalyst Pharmaceuticals Inc
Emalex Biosciences Inc
Evero Health Ltd
H. Lundbeck AS
SOM Biotech SL
Teva Pharmaceutical Industries Ltd
Tourette Syndrome - Drug Profiles
alpha-dihydrotetrabezine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bevantolol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CPP-115 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
deutetrabezine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tourette Syndrome - Dormant Projects
Tourette Syndrome - Discontinued Products
Tourette Syndrome - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Figures
Number of Products under Development for Tourette Syndrome, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Stage and Molecule Types, H2 2020
List of Tables
Number of Products under Development for Tourette Syndrome, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Tourette Syndrome - Pipeline by Adeptio Pharmaceuticals Ltd, H2 2020
Tourette Syndrome - Pipeline by Asarina Pharma AB, H2 2020
Tourette Syndrome - Pipeline by Catalyst Pharmaceuticals Inc, H2 2020
Tourette Syndrome - Pipeline by Emalex Biosciences Inc, H2 2020
Tourette Syndrome - Pipeline by Evero Health Ltd, H2 2020
Tourette Syndrome - Pipeline by H. Lundbeck AS, H2 2020
Tourette Syndrome - Pipeline by SOM Biotech SL, H2 2020
Tourette Syndrome - Pipeline by Teva Pharmaceutical Industries Ltd, H2 2020
Tourette Syndrome - Dormant Projects, H2 2020
Tourette Syndrome - Discontinued Products, H2 2020